🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy of orelabrutinib combined with R-CHOP vs. R-CHOP a...
Status
Completed
Location
Anhui Province Cancer Hospital
Start Date
2021-12-22
Trial ID
NCT05051891
Treatments Being Tested
The main purpose of the PETAL trial is to determine whether patients with a...
Status
Completed
Location
Department of Hematology, University Hospital Essen
Start Date
2007-11
Trial ID
NCT00554164
Treatments Being Tested
The goal of this clinical research study is to learn the effect of combinin...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2008-03
Trial ID
NCT00651755
Treatments Being Tested
Patients with previously untreated diffuse large B-cell lymphoma will recei...
Status
Completed
Location
Skåne University Hospital, Dept. of Oncology
Start Date
2012-06
Trial ID
NCT01622439
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of ruxoliti...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-12-16
Trial ID
NCT07278856
Treatments Being Tested
The combination of rituximab, cyclophosphamide, doxorubicin, vincristine, a...
Status
Unknown
Location
Guangdong Provincial People's Hospital
Start Date
2015-09
Trial ID
NCT02428751
Treatments Being Tested
This is a phase 1B, multi-center, dose-finding study of glofitamab administ...
Status
Completed
Location
University of Alabama Medical Center
Start Date
2018-03-13
Trial ID
NCT03467373
Diffuse large B-cell lymphoma (DLBCL) is an aggressive subset of non-Hodgki...
Status
Terminated
Location
MD Anderson
Start Date
2021-07-19
Trial ID
NCT05022797
Treatments Being Tested
Blinatumomab (BLINCYTO) is a bi-specific T-cell engaging (BiTE®) antibody c...
Status
Completed
Location
Chu Amiens
Start Date
2019-07-05
Trial ID
NCT03931642
Treatments Being Tested
To retrospectively collect information on DLBCL patients treated with orela...
Status
Unknown
Location
Hematological Department, People's Hospital of Jiangsu Province
Start Date
2023-09-01
Trial ID
NCT06015464
Treatments Being Tested